New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
NYS Entity Status
NYS Filing Date
JULY 22, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - 30 LINDEN LLC
AROUND THE WEB
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
- Neighborhoods That Play Hard to Get
By STEFANOS CHEN - Friday Aug 11, 2017
In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.
- Dermatologist says 'cell callous' is joining 'tech neck' as a 21st century health issue
By Leah Garchik - Tuesday May 30, 2017
Callous and corn creams designed for feet may help, or a superficial cortisone shot. But sufferers should adjust their phone grips. "Palm it," says the doc, "or better yet, put it down."
- ‘The Mindy Project': Ike Barinholtz ‘Started Crying’ When Mindy Kaling Wrote His Injury Into Final Season
By Carli Velocci, provided by
- Thursday Jul 27, 2017
‘The Mindy Project': Ike Barinholtz ‘Started Crying’ When Mindy Kaling Wrote His Injury Into Final SeasonThe actor broke his neck while performing a stunt on his upcoming filmBarinholtz, who plays Nurse Morgan Tookers, broke his neck a few weeks ago while performing a fall stunt on his upcoming film “The Pact.”According to People, Barinholtz had two fractured cervical vertebrae in his neck, is now prescribed to wear a brace by doctors.“Luckily, I’ve had great doctors who have really helped me with my recovery,” he told People.Barinholtz was on the top of his comedy game at the panel, cracking jokes and jumping in to tout his (not real) connections to Oprah Winfrey and how he’s still the Elliot Gould of the series.
- Linden Lab launches open beta for social VR platform Sansar
By Dean Takahashi - Monday Jul 31, 2017
Linden Lab has opened the creator beta version of its Sansar social virtual reality platform to the public. It’s all part of a larger vision to bring us the Metaverse, the immersive virtual world that sci-fi fans have dreamed about for decades. After four years of development, the San Francisco company that brought us the […]
- Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer
By Alex Lash - Monday Jul 24, 2017
The first immunotherapy approved in the U.S. to treat head and neck cancer has failed a big test, but it’s unclear if the FDA will exercise its right to pull it from the market. Merck (NYSE: MRK) announced late Monday that its blockbuster cancer drug pembrolizumab (Keytruda) did not meet its main goal of helping […]